Orchid Cellmark | GenomeWeb

Orchid Cellmark

MP Biomedicals has named Todd Nelson president and CEO, replacing Milan Panic, founder and CEO, who will remain as chairman of the company.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said that it has successfully completed its cash tender offer for all outstanding shares of Orchid Cellmark.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America again is extending its bid to acquire Orchid Cellmark.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Orchid Cellmark reported on Monday a 7 percent decline year over year in third-quarter revenues.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said it has extended its cash tender offer to purchase Orchid Cellmark to 5 p.m. EDT Oct. 7.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.